[{"data":1,"prerenderedAt":58},["ShallowReactive",2],{"team":3},{"id":4,"advisors":5,"board":26,"executives":36,"extension":54,"meta":55,"stem":56,"__hash__":57},"team\u002Fdata\u002Fteam.yml",[6,10,13,16,20,23],{"name":7,"credentials":8,"focus":9},"Rakesh Dixit","PhD","ADC Discovery & Development",{"name":11,"credentials":8,"focus":12},"Tracy Handel","Pharmacology, GPCRs",{"name":14,"credentials":8,"focus":15},"Cath Hutchings","Target selection; mAb discovery",{"name":17,"credentials":18,"focus":19},"Fred Ramsdell","PhD, Nobel Laureate","Oncology",{"name":21,"credentials":8,"focus":22},"Scott Struthers","Executive",{"name":24,"credentials":25,"focus":19},"Napoleone Ferrara","MD",[27,30,33],{"name":28,"affiliation":29},"Dan Bradbury","Former Amylin CEO",{"name":31,"affiliation":32},"Mike Goguen","Two Bear Capital",{"name":34,"credentials":8,"affiliation":35},"Mauro Mileni","Abilita Therapeutics CEO",[37,39,42,45,48,51],{"name":34,"credentials":8,"role":38},"Chief Executive Officer & Founder",{"name":40,"credentials":8,"role":41},"Anke Kretz-Rommel","Chief Scientific Officer",{"name":43,"credentials":8,"role":44},"Christopher Roth","Senior Vice President of Research",{"name":46,"credentials":8,"role":47},"Matthew Ritter","Chief Business Officer",{"name":49,"credentials":8,"role":50},"Scott Forrest","Business & Finance Advisor",{"name":52,"role":53},"James Schmidt","Chief Financial Officer","yml",{},"data\u002Fteam","fulKit1NNFGjqyOVAhUyks_7BPN10hda95hL0O2rsbY",1779487983544]